EFFICACY AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE THROUGH 5 YEARS: FINAL RESULTS FROM THE IM-UNITI LONG-TERM EXTENSION

William Sandborn  ¹     Paul Rutgeerts  ²     John Lynch  ³     Rory Rebuck  ³     Yuhua Wang  ³     Bin Zou  ⁴     Christopher Gasink     Omoniyi J. Adedokun     Bruce E. Sands     Stephen B Hanauer     Stephan Targan     Subrata Ghosh     Willem de Villiers     Jean-Frederic Colombel     Brian G. Feagan    
¹ University of California San Diego,La Jolla,United States
² Katholieke Univeriteit Leuven Dept. of Gastroenterology,Leuven,Belgium
³ Janssen Research & Development, LLC,Spring House,United States
⁴ J

Session
IBD: Clinical trials II

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)